Kristen Harrington-Smith
Direktor/Vorstandsmitglied bei EFFECTOR THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Profil
Kristen Harrington-Smith is currently an Independent Director at eFFECTOR Therapeutics, Inc. and the Chief Commercial Officer at ADC Therapeutics SA. Prior to her current roles, she was the Chief Commercial Officer & Senior Vice President at ImmunoGen, Inc. from 2021 to 2022 and the US Commercial Head-Hematology at Novartis Pharmaceuticals from 2020 to 2021.
She received her undergraduate degree from Williams College and her MBA from Kenan-Flagler Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.04.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Kristen Harrington-Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.02.2022 |
| ADC THERAPEUTICS SA | Corporate Officer/Principal | 17.11.2022 |
Ehemalige bekannte Positionen von Kristen Harrington-Smith
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 16.11.2022 |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Corporate Officer/Principal | 01.11.2021 |
Ausbildung von Kristen Harrington-Smith
| Williams College | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |